Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
<strong>Background/objective </strong>The aim of this study was to evaluate relative performance of composite measures in psoriatic arthritis and assess the impact of structural damage and functional disability on outcomes during ixekizumab treatment. <br><strong> Methods <...
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
BMJ Publishing Group
2022
|